WALTHAM, Mass. – The Massachusetts Medical Society (MMS), a statewide professional association for physicians and medical students, supporting more than 25,000 members, today announced that it is accepting submissions for its Information Technology in
Medicine awards program.
The awards, presented to one medical student and one resident each year, recognize the development of an information technology tool that helps physicians practice medicine, teach medicine, or pursue clinical research. Each winner receives $5,000.
Applicants must be a student, resident, or fellow at the time of submission and be enrolled in one of the four Massachusetts medical schools or a Massachusetts hospital or training program. Applications are due by Sunday, Jan. 8, 2023.
The awards are sponsored by Click Therapeutics, Inc., (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments.
The MMS Information Technology in Medicine awards have been presented annually since 2001 and many winners have seen their projects make indelible marks on science, medicine, and patient care.
“The Massachusetts Medical Society has a long-standing tradition of supporting clinicians and clinician scientists in building the next generation health care innovation to improve patient care, quality, and access,” said Dr. Jennifer Joe, chair of the
Massachusetts Medical Society’s Committee on Information Technology. “We are delighted to be working with innovative partners like Click Therapeutics to continue to make Massachusetts the healthcare innovation hub that it is and to support our students
and researchers to continue to be world leaders in traditional and non-traditional new fields, like data and digital health. The Massachusetts Medical Society’s IT awards are an important part of this mission.”
Last year’s winner, Dr. Andrew Chu, a resident physician in the Harvard Affiliated Emergency Medicine Residency (HAEMR) and concurrent innovation fellow at the MGH Healthcare Transformation Lab, identified a need for tech-based support during the height
of the COVID-19 pandemic.
Chu and Dr. Jared Conley, his fellowship director, co-created a pair of mobile apps, MGH ACLS (Advanced Cardiac Life Support) and PALS (Pediatric Advanced Life Support), used by clinicians for cardiac resuscitation at the bedside.
MGH ACLS was launched during the COVID- 19 pandemic, and there are currently nearly 30,000 clinician-users in more than 150 countries and more than 500 clinician users daily.
In 2019, Dr. Marc Succi received the award for his establishment of Medically Engineered Solutions in Healthcare (MESH) Incubator, an in-house innovation and entrepreneurship center at Mass General Brigham (MGB) and Harvard Medical School.
In 2013, Dr. YiDing Yu won an award for the creation of Twiage, a secure mobile app-to-web platform that allows medics to send real-time data in the field to doctors in the Emergency Department (ED). The communication between EMS and ED is currently carried
about by a one-time radio communication. Twiage technology is used currently utilized by more than 100 leading hospitals and health networks across the United States.
For more information on the awards and to apply, click here.
The Massachusetts Medical Society (MMS) is the statewide professional association for physicians and medical students, supporting 25,000 members. We are dedicated to educating and advocating for the physicians of Massachusetts and patients locally and nationally. A leadership voice in health care, the MMS contributes physician and patient perspectives to influence health-related legislation at the state and federal levels, works in support of public health, provides expert advice on physician practice management, and addresses issues of physician well-being. Under the auspices of the NEJM Group, the MMS extends our mission globally by advancing medical knowledge from research to patient care through the New England Journal of Medicine, NEJM Catalyst, and the NEJM Journal Watch family of specialty publications, and through our education products for health care professionals: NEJM Knowledge+, NEJM Resident 360, and our accredited and comprehensive continuing medical education programs.
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program has entered a pivotal, fully remote, randomized, controlled trial on the Verily platform for the treatment of Major Depressive Disorder (MDD) in up to 360 adults. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including MDD, Schizophrenia, Migraine, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome (ACS), Obesity and more. For more information on Click, visit ClickTherapeutics.com.
